Linagliptin Impurity B
| CAS No. | : 2138392-83-1 |
| Mol F. | : C26H21BrN8O2 |
| Mol W. | : 557.41 |
| Cat No. | : SA49906 |
- Description
- Quick Enquiry / RFQ
Description
| Product Name | Linagliptin Impurity B |
| Synonyms | 8-Bromo-3-methyl-1,7-bis((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
8-bromo-3-methyl-1,7-bis((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione |
| Related API | Linagliptin |
| Category | Impurities |
Linagliptin Impurity B product with CAS: 2138392-83-1 is also known as 8-Bromo-3-methyl-1,7-bis((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione. This product can be used as a working standard or secondary reference standard. Additional internal validation as per respective FDA regulations/guidelines may require. Linagliptin Impurity B is generally used for Quality Control (QC), Quality Assurance (QA) during commercial production of Linagliptin and its related formulations. Moreover,8-Bromo-3-methyl-1,7-bis((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione is also used in the process of Abbreviated New Drug Application (ANDA) filing to FDA and toxicity study of respective drug formulation.
If you need different pack size / quantity, please contact us or email us at [email protected]
